Molecular biology plays an important role in the diagnosis and treatment of cancer. On a biological level, the development of cancer is characterized by the acquisition of genetic mutations which cause abnormal cell growth, eventually resulting in malignant disease. Understanding how molecular damage can cause these cancer-driving mutations can help design optimal treatment regimens
-
JUL 26, 2023 | 3:10 PM
C.E. CREDITS
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 12:15 PM
C.E. CREDITS
Genetically modified cell models accelerate the development of safe and effective therapeutics, making them indispensable in the quest for new drugs. Through manipulation of cell line geneti...
Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing, scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin r...
JUL 18, 2023 2:00 PM EDT
C.E. CREDITS
Worldwide gastric cancer is the 5th most common cancer and the 4th leading cause of cancer deaths. Its highest incidence rates are in east Asia and eastern Europe with low incidence rates in...
July 18, 2023 12:30PM EDT
C.E. CREDITS
Lung cancer is still responsible for most cancer-related deaths for both genders in the United States. Traditionally, diagnosis and management of patients has been based on tissue biopsy to...
JUN 27, 2023 | 11:00 AM
C.E. CREDITS
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization. Many cancers can be cu...
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
Achieving consistent AAV quantification with the QuantStudio Absolute Q AutoRun dPCR Suite Accurate quantification of AAV vectors is crucial for quality control and timely decision-making du...
JUN 08, 2023 | 9:00 AM
C.E. CREDITS
In the emergency department, distinguishing between bacterial and viral infections can be challenging, leading to inappropriate use of antibiotics that may contribute to the development of b...
APR 25, 2023 | 8:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
APR 25, 2023 | 10:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...
Date: April 20, 2023 Time: 7:00am (PST), 10:00am (EST), 4:00pm (CET) he study of human evolution. A decade ago, his team managed to sequence the Neanderthal and Denisovan genomes which resul...
APR 19, 2023 | 10:00 AM
C.E. CREDITS
Date: April 18, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Whilst a decade ago the prognosis of lung cancer patients has been very disappointing, nowadays a substantial evolutio...
APR 05, 2023 | 1:00 PM
C.E. CREDITS
Date: April 04, 2023 Time: 10:00pm (PDT), Date: April 05, 2023 Time: 2:00am (EDT), 7:00am (CEST), 1:00pm (SGT) This seminar provides an overview of fluorescence microscopy in cancer research...
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...